These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34013213)

  • 21. Characterization of functions in parasite growth and virulence of four Toxoplasma gondii genes involved in lipid synthesis by CRISPR-Cas9 system.
    Liu J; Li TT; Liang QL; Elsheikha HM; Zhao DY; Zhang ZW; Xu XP; Zhu XQ; Wang M
    Parasitol Res; 2021 Nov; 120(11):3749-3759. PubMed ID: 34499198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secreted effectors in Toxoplasma gondii and related species: determinants of host range and pathogenesis?
    English ED; Adomako-Ankomah Y; Boyle JP
    Parasite Immunol; 2015 Mar; 37(3):127-40. PubMed ID: 25655311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Toxoplasma gondii Rhoptry Kinome Is Essential for Chronic Infection.
    Fox BA; Rommereim LM; Guevara RB; Falla A; Hortua Triana MA; Sun Y; Bzik DJ
    mBio; 2016 May; 7(3):. PubMed ID: 27165797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host.
    Saeij JP; Boyle JP; Boothroyd JC
    Trends Parasitol; 2005 Oct; 21(10):476-81. PubMed ID: 16098810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-Wide CRISPR Screen Identifies Host Factors Required by
    Wu SZ; Wei HX; Jiang D; Li SM; Zou WH; Peng HJ
    Front Cell Infect Microbiol; 2019; 9():460. PubMed ID: 32039045
    [No Abstract]   [Full Text] [Related]  

  • 26. Investigative study on the role of the Toxo 5699 gene in the Toxoplasma gondii lytic cycle using the CRISPR/Cas9 system.
    De Silva JR; Ching XT; Lau YL
    Trop Biomed; 2020 Jun; 37(2):324-332. PubMed ID: 33612802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhoptry Proteins ROP5 and ROP18 Are Major Murine Virulence Factors in Genetically Divergent South American Strains of Toxoplasma gondii.
    Behnke MS; Khan A; Lauron EJ; Jimah JR; Wang Q; Tolia NH; Sibley LD
    PLoS Genet; 2015 Aug; 11(8):e1005434. PubMed ID: 26291965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental toxoplasmosis in mice and rabbits. Virulence and cyst formation of Toxoplasma gondii.
    Pettersen EK
    Acta Pathol Microbiol Scand B; 1977 Feb; 85B(1):95-102. PubMed ID: 842354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Research progress on genotype and genotype-associated pathogenesis of Toxoplasma gondii].
    Wang L; Shen JL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Aug; 31(4):319-24. PubMed ID: 24812887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mSphere of Influence: Ushering in the CRISPR Revolution to
    Guerra AJ
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31270169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ROP18 is a key factor responsible for virulence difference between Toxoplasma gondii and Neospora caninum.
    Lei T; Wang H; Liu J; Nan H; Liu Q
    PLoS One; 2014; 9(6):e99744. PubMed ID: 24927100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of deletion of gra17 and gra23 genes on the growth, virulence, and immunogenicity of type II Toxoplasma gondii.
    Li TT; Wang JL; Liang QL; Sun LX; Zhang HS; Zhang ZW; Zhu XQ; Elsheikha HM
    Parasitol Res; 2020 Sep; 119(9):2907-2916. PubMed ID: 32686022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and biological analysis revealed genetic diversity and high virulence strain of Toxoplasma gondii in Japan.
    Fukumoto J; Yamano A; Matsuzaki M; Kyan H; Masatani T; Matsuo T; Matsui T; Murakami M; Takashima Y; Matsubara R; Tahara M; Sakura T; Takeuchi F; Nagamune K
    PLoS One; 2020; 15(2):e0227749. PubMed ID: 32012177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vivo CRISPR Screen Identifies TgWIP as a Toxoplasma Modulator of Dendritic Cell Migration.
    Sangaré LO; Ólafsson EB; Wang Y; Yang N; Julien L; Camejo A; Pesavento P; Sidik SM; Lourido S; Barragan A; Saeij JPJ
    Cell Host Microbe; 2019 Oct; 26(4):478-492.e8. PubMed ID: 31600500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9 and glycomics tools for
    Gas-Pascual E; Ichikawa HT; Sheikh MO; Serji MI; Deng B; Mandalasi M; Bandini G; Samuelson J; Wells L; West CM
    J Biol Chem; 2019 Jan; 294(4):1104-1125. PubMed ID: 30463938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virulence-related gene wx2 of Toxoplasma gondii regulated host immune response via classic pyroptosis pathway.
    Ma Z; Li Z; Jiang R; Li X; Yan K; Zhang N; Lu B; Huang Y; Dibo N; Wu X
    Parasit Vectors; 2022 Dec; 15(1):454. PubMed ID: 36471417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic and transcriptomic analyses of early and late-chronic Toxoplasma gondii infection shows novel and stage specific transcripts.
    Garfoot AL; Wilson GM; Coon JJ; Knoll LJ
    BMC Genomics; 2019 Nov; 20(1):859. PubMed ID: 31726967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated bioinformatic and targeted deletion analyses of the SRS gene superfamily identify SRS29C as a negative regulator of Toxoplasma virulence.
    Wasmuth JD; Pszenny V; Haile S; Jansen EM; Gast AT; Sher A; Boyle JP; Boulanger MJ; Parkinson J; Grigg ME
    mBio; 2012 Nov; 3(6):. PubMed ID: 23149485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/Cas9 and genetic screens in malaria parasites: small genomes, big impact.
    Ishizaki T; Hernandez S; Paoletta MS; Sanderson T; Bushell ESC
    Biochem Soc Trans; 2022 Jun; 50(3):1069-1079. PubMed ID: 35621119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of innate immunity by Toxoplasma gondii virulence effectors.
    Hunter CA; Sibley LD
    Nat Rev Microbiol; 2012 Nov; 10(11):766-78. PubMed ID: 23070557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.